GUGGENHIME ANDREW (CFO, CBO) sold 8.7% of their position (10K shares) of VAXCYTE, INC. on the open market
Open‑market sale worth $530.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/19/2026ACC: 0001230724-26-000010
-10K
Net shares
Net seller
$530.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$5.35
Trade value
$53.50K
% of position
9.6%
6/18/2026
104.39K→114.39K
Common Stock
Direct
Shares
−10K
Price / share
$53.00
Trade value
$530K
% of position
8.7%
6/18/2026
114.39K→104.39K
Total
Net shares
+0.00
Net value
-$476.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/18/2026 | M · Option Exercise | +10K | $5.35 | $53.50K | 9.6% | 104.39K | 114.39K |
| Common Stock Direct | 6/18/2026 | S · Sale | −10K | $53.00 | $530K | 8.7% | 114.39K | 104.39K |
| Total | +0.00 | -$476.50K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
5.35
Held after
236.83K
Exercisable
—
6/18/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock10K shares | 6/18/2026 | M · Option Exercise | −10K | 5.35 | — | 236.83K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned61.85K
Total
61.85K indirect61.85K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 61.85K | Indirect |
| Total | 61.85K | 61.85K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported